July 2019

  • Prof. Dr. med. Britta Siegmund: former doctoral student and post-doc (1995 to 2000) of the Division of Clinical Pharmacology, since 2013 Chair of Gastroenterology, Charité, Berlin, was elected Vice President of the Deutsche Forschungsgemeinschaft.


  • PD Dr. med. David Anz: Bewilligung des DFG-Einzelantrags "Bedeutung des Chemokins CCL22 in der Aufrechterhaltung immunologischer Toleranz"; Förderung 241.000 Euro über drei Jahre.


  • Prof. Dr. med. Sebastian Kobold: Bewilligung des DFG-Einzelantrags "Rolle von Interleukin-22 in der Metastasierung des Mamma- und Lungenkarzinoms"; Förderung 370.000 Euro über drei Jahre.


  • Prof. Dr. med. Sebastian Kobold: appointed W2-Professor for Experimental Immunoncology in the Division of Clinical Pharmacology.


  • Our manuscript describing a novel cell therapy platform, the synthetic agonist receptor (SAR) T cells for cancer therapy was accepted in Clinical Cancer Research (JIF 10.2). Congratulations to Clara and Reda who spearheaded this work!


  • Our manuscript on breast cancer metastasis and the functional link to breast cancer phenotype has appeared online at Science Advances (JIF 11.5). Congratulation to Bruno, Ana, Conny, Daria and Javi for their outstanding contributions.

June 2019


  • Prof. Dr. phil. nat. Carolin Daniel: appointed W2-Professor for Immunmodulation in the Division of Clinical Pharmacology (will continue leading the group Immunotolerance at the Institute for Diabetic Research, Helmholtz Zentrum Munich).



April 2019

  • Stefanie Lesch, M. Sc. won the "Posterpreis" – presented by Lena Völkl – at the ITOC Congress 2019 in Vienna.



March 2019

  • Manuscript PD Dr. med. David Anz: CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. Journal of Experimental Medicine 2019; 116:5514-5522. JIF 10.8.




January 2019

  • PD Dr. med. Sebastian Kobold receives the Johann-Georg-Zimmermann Award for Cancer Research 2019.






December 2018

  • Prof. Dr. med. Stefan Endres:  member of the scientific advisory board (Wissenschaftlicher Beirat) of the "Bundesärztekammer".



October 2018

  • Manuscript Rataj et al. "High affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy" was accepted for publication in the British Journal of Cancer. Congratulations to the team and special thanks to Justyna Ogonek and Nicholas Tokarew who took care of the revision.

  • DFG approval for purchasing an in vivo imaging system IVIS (e. g. for in vivo quantification of tumor growth); 361.000 Euro will be financed at 50 % each by the DFG and by the University Hospital.   



August 2018

  • The manuscript "PD1-CD28 fusion protein enables CD4+ T cell help for adoptive T cell therapy in models of pancreatic cancer and non-Hodgkin-lymphoma" was accepted for publication in Frontiers in Immunology 2018. Congratulations to Felicitas Rataj, Fabian Kraus and their team.



July 2018

  • Dr. Julia Ahlfeld and Ph. D. Jin Zhang were awarded funding by the Friedrich Baur Foundation.   



May 2018

  • Three members of the Division have been granted funding as Principal Investigators within one renewed and two new Collaborative Research Centers (Sonderforschungsbereiche) der Deutschen Forschungsgemeinschaft: Prof. Dr. Simon Rothenfußer, SFB-Transregio 237 “Nukleinsäure-Immunität” (Bonn, München und Dresden); Prof. Dr. Max Schnurr, SFB 1321 “Modellierung und Targeting des Pankreaskarzinoms”; and PD Dr. Peter Düwell, SFB 1123: “Athersklerose: Mechanismen und Netzwerke therapeutischer Zielstrukturen”.

  • Prof. Dr. Stefan Endres appointed as Member of the Kuratorium (Board of Trustees) des Deutschen Museums München.



April 2018

  • Congratulations to Anamarija Markota, Adrian Gottschlich and Felicitas Rataj for their articles accepted in Human Vaccines and Immunotherapies, Translational Cancer Research and Translation Lung Cancer Research!
  • Justyna Ogonek was awarded funding from the "Verein zur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der LMU", congratulations!



December 2017

  • Der Immunologe Prof. Veit Hornung klärt zentrale Abwehrmechanismen des angeborenen Immunsystems auf. Jetzt bekommt er für seine Arbeiten den wichtigsten deutschen Forschungspreis: den Leibniz-Preis 2017 der Deutschen Forschungsgemeinschaft. Veit Hornung hat in der Abteilung für Klinische Pharmakologie promoviert und war Postdoktorand in der Abteilung (DE/

November 2017

  • Our manuscript on the regulation of Interleukin-22 in cancer was released in PNAS Congratulations to Cornelia, Peter, Adrian and Ana for the huge efforts that went into this manuscript! (DE)


October 2017

  • Prof. Dr. Simon Rothenfusser: Gemeinsamer Projektantrag mit Anne Krug (LMU) und Giovanna Barba-Späeth (Institut Pasteur, Paris) im Rahmen der ANR-DFG Cooperation 2017 in Natural, Life and Engineering Sciences bewilligt
  • Dr. Felicitas Rataj has been awarded a 2-year fellowship from Peter-and-Traudl-Engelhorn Foundation

August 2017

  • Dr. Lars König: Antrag auf Projektförderung bei der Else Kröner Fresenius-Stiftung in Höhe von 297.973 Euro wurde bewilligt
  • PD Dr. Sebastian Kobold mit ERC Starting Grant ausgezeichnet (DE)

July 2017

  • On July 7th the Division welcomed as a guest Prof. Jules Hoffmann, Université de Strasbourg. Prof. Hoffmann is a world leader in innate immunity. He received the Nobel Prize in Physiology and Medicine in 2011 for his discovery of the toll system in insects.


May 2017

  • PD Dr. Sebastian Kobold und Prof. Dr. Stefan Endres: Antrag Onkattract beim Bundesministerium für Bildung und Forschung, Projektträger Jülich wurde mit 1.202.588 Euro bewilligt

February 2017

  • Adrian Gottschlich was selected for the "Studienstiftung des deutschen Volkes"
  • Severin Jacobi was selected for a Jose-Carreras-Foundation doctoral student fellowship
  • Angelina Krächan was selected for a Mildreed-Scheel-Foundation doctoral
    student fellowship
  • PD Dr. Sebastian Kobold was awarded the Hugo-Wilhelm-von Ziemssen-Award
    for medical research

January 2017

  • PD Dr. Sebastian Kobold and Prof. Dr. Stefan Endres: New research cooperation with TCR2 Therapeutics Inc. located in Cambridge, USA to improve T cell-based therapy (DE/EN)




October 2016

  • PD Dr. med. Sebastian Kobold received the Vincenz-Czerny Award 2016 by the German Society for Hematology and Medical Oncology

September 2016

  • Max Knott and Moritz Schmidbauer were selected into the "MeCuM StEP - Studierende Exzellenz Programm" LMU

August 2016

  • Cornelia Ochs was awarded funding by the CIPSMwomen program

July 2016

  • Stefan Stoiber was awarded funding by the LMUexcellent student research program
  • Our manuscript "Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases" was accepted for publication in BMC Cancer, congratulations to Amanda and her team!
  • AG Anz was awarded funding by the Wilhelm-Sander-Stiftung

June 2016

  • Dr. Felicitas Rataj was awarded funding by the Friedrich Baur Foundation
  • PD Dr. Sebastian Kobold was awarded funding by the LMUExcellent program
  • The Clinician Scientist Program Cancer Immunotherapy (CSP Munich) coordinated by Prof. Marion Subklewe has been selected for funding by the Else Kröner Fresenius Stiftung. PD Dr. Sebastian Kobold is one of the PI of the program. Congratulations!

May 2016

  • Our manuscript "A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice" was accepted for publication in Oncoimmunology. Congratulations to Gabi and her team!

April 2016

  • PD Dr. med. Sebastian Kobold receives the BMS-Melanoma Research Alliance Young Investigator Award

  • PD Dr. med. Sebastian Kobold is awarded funding by the Verein zur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der Ludwig-Maximilians-Universität München

  • Fabian Kraus is awarded a travel grant to the CIMT meeting 2016 in Mainz by the Studienstiftung des Deutschen Volkes

March 2016

  • Dr. Felicitas Rataj is awarded funding from the CIPSM Gender Program

  • Stefanie Lesch is awarded funding from the CIPSM Gender Program

  • Clara Karches is awarded funding from the CIPSM Gender Program

January 2016

  • PD Dr. Sebastian Kobold is selected for the career advancement award of the Ernst Jung Stiftung